Detalles de la búsqueda
1.
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review.
Oncologist
; 29(5): e580-e600, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309719
2.
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer.
Anticancer Drugs
; 35(5): 459-461, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451823
3.
Acute heart failure following pazopanib treatment: a literature review featuring two case reports.
Anticancer Drugs
; 35(3): 302-304, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38018812
4.
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors.
Anticancer Drugs
; 34(6): 783-790, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729111
5.
The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy.
J Oncol Pharm Pract
; 28(4): 785-793, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878976
6.
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.
J Chemother
; : 1-7, 2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497444
7.
Advances in the Early Detection of Hepatobiliary Cancers.
Cancers (Basel)
; 15(15)2023 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37568696
8.
The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors.
Cancer Biomark
; 34(2): 189-199, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958005
Resultados
1 -
8
de 8
1
Próxima >
>>